1-6 of 6
Authors: Roelf Valkema
Journal Article
796. P02.05 NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY ACTIVE SURVEILLANCE VERSUS STANDARD SURGERY FOR OESOPHAGEAL CANCER (SANO-TRIAL): A MULTICENTRE STEPPED-WEDGE CLUSTER-RANDOMISED NONINFERIORITY TRIAL Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.392, https://doi.org/10.1093/dote/doae057.392
Published: 02 September 2024
Journal Article
283. 18F-FDG PET/MRI FOR RESTAGING ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.116, https://doi.org/10.1093/dote/doad052.116
Published: 30 August 2023
Journal Article
453. TREATMENT AND SURVIVAL OF PATIENTS WITH A POSITIVE RESECTION MARGIN AFTER NEOADJUVANT CHEMORADIOTHERAPY AND ESOPHAGECTOMY Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.240, https://doi.org/10.1093/dote/doad052.240
Published: 30 August 2023
Journal Article
220. INDUCTION CHEMOTHERAPY FOLLOWED BY RESTAGING AND SURGERY FOR ADVANCED ESOPHAGEAL CANCER Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.073, https://doi.org/10.1093/dote/doad052.073
Published: 30 August 2023
Journal Article
221. INTERVAL METASTASES AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL CANCER: A MULTICENTER OBSERVATIONAL COHORT STUDY Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.074, https://doi.org/10.1093/dote/doad052.074
Published: 30 August 2023
Journal Article
266. EXTENSION OF FDG-PET-BASED RADIOMIC MODELS ON IDENTIFICATION OF PATIENTS WITH RESIDUAL ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.266, https://doi.org/10.1093/dote/doac051.266
Published: 24 September 2022
